CIK 1848809
Velan Capital Investment Management LP
Institutional 13F holdings & portfolio
Holdings
46
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1–46 of 46
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | 101K | $1M+ | SH |
| CDTX | CIDARA THERAPEUTICS INC | 108K | $1M+ | SH |
| TARA | PROTARA THERAPEUTICS INC | 2.8M | $1M+ | SH |
| HRTX | HERON THERAPEUTICS INC | 8.8M | $1M+ | SH |
| ABVX | ABIVAX SA | 67K | $1M+ | SH |
| EVMN | EVOMMUNE INC | 507K | $1M+ | SH |
| MLYS | MINERALYS THERAPEUTICS INC | 151K | $1M+ | SH |
| LNTH | LANTHEUS HLDGS INC | 75K | $1M+ | SH |
| AVTX | AVALO THERAPEUTICS INC | 264K | $1M+ | SH |
| ESPR | ESPERION THERAPEUTICS INC NE | 1.2M | $1M+ | SH |
| JSPR | JASPER THERAPEUTICS INC | 2.4M | $1M+ | SH |
| VRCA | VERRICA PHARMACEUTICALS INC | 472K | $1M+ | SH |
| NSPR | INSPIREMD INC | 2.1M | $1M+ | SH |
| RAPT | RAPT THERAPEUTICS INC | 108K | $1M+ | SH |
| STRO | SUTRO BIOPHARMA INC | 312K | $1M+ | SH |
| TERN | TERNS PHARMACEUTICALS INC | 70K | $1M+ | SH |
| SNDX | SYNDAX PHARMACEUTICALS INC | 130K | $1M+ | SH |
| VRDN | VIRIDIAN THERAPEUTICS INC | 87K | $1M+ | SH |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 352K | $1M+ | SH |
| TRVI | TREVI THERAPEUTICS INC | 205K | $1M+ | SH |
| PROF | PROFOUND MED CORP | 286K | $1M+ | SH |
| KZIA | KAZIA THERAPEUTICS LTD | 300K | $1M+ | SH |
| RZLT | REZOLUTE INC | 750K | $1M+ | SH |
| TENX | TENAX THERAPEUTICS INC | 83K | $1M+ | SH |
| EDSA | EDESA BIOTECH INC | 688K | $500K+ | SH |
| MPLT | MAPLIGHT THERAPEUTICS INC | 29K | $500K+ | SH |
| — | TREVI THERAPEUTICS INC | 39K | $100K–$500K | SH (Call) |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 7K | $100K–$500K | SH |
| VTYX | VENTYX BIOSCIENCES INC | 40K | $100K–$500K | SH |
| CTMX | CYTOMX THERAPEUTICS INC | 80K | $100K–$500K | SH |
| PTGX | PROTAGONIST THERAPEUTICS INC | 4K | $100K–$500K | SH |
| NRIX | NURIX THERAPEUTICS INC | 16K | $100K–$500K | SH |
| OVID | OVID THERAPEUTICS INC | 160K | $100K–$500K | SH |
| GOSS | GOSSAMER BIO INC | 70K | $100K–$500K | SH |
| IMNM | IMMUNOME INC | 10K | $100K–$500K | SH |
| DSGN | DESIGN THERAPEUTICS INC | 20K | $100K–$500K | SH |
| IMMX | IMMIX BIOPHARMA INC | 35K | $100K–$500K | SH |
| CNTX | CONTEXT THERAPEUTICS INC | 100K | $100K–$500K | SH |
| REPL | REPLIMUNE GROUP INC | 15K | $100K–$500K | SH |
| LRMR | LARIMAR THERAPEUTICS INC | 33K | $100K–$500K | SH |
| XLO | XILIO THERAPEUTICS INC | 170K | $100K–$500K | SH |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 13K | $100K–$500K | SH |
| PRQR | PROQR THRAPEUTICS N V | 45K | $50K–$100K | SH |
| DTIL | PRECISION BIOSCIENCES INC | 20K | $50K–$100K | SH |
| PYXS | PYXIS ONCOLOGY INC | 40K | $15K–$50K | SH |
| PMVP | PMV PHARMACEUTICALS INC | 35K | $15K–$50K | SH |